NAVAL MEDICAL RESEARCH UNIT SIX is seeking to purchase laboratory reagents to be used for molecular diagnosis of Influenza virus, adenovirus, Metapneumovirus, Enterovirus, Rhinovirus and Respiratory Syncytial Virus in the Virology & Emerging Infections Department. Specifically, requirement involves PCR enzymes for reverse transcription, real-time platforms, and sanger sequencing that are used for detection of human influenza viruses .

NAMRU-6 assays have been validated using the TaqMan 7500/7500 Fast Real time PCR system and therefore, compatibility of the consumables is a requirement. The RT-PCR assays have been developed independently for each SOP and involve much time and effort by laboratory technicians, and supervisors for final approval. Reagents used must remain the same as the ones indicated in the SOPs, otherwise the design and validation of these processes would have to be initiated from zero, which will delay all processing and the timely diagnosis of public health relevant pathogens.

The high sensitivity of some reagents, must keep the cold chain, some products require room temperature, other needs to be refrigerated or frozen during their transportation and storage.

If capable sources are not identified through this notice, then NAMRU 6 intends to award a sole source contract under the authority of 13.106-1(b)(i) to Life Technologies Corp.

This pre-solicitation is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.

Capability statements are due by 12:00 PM Local Time, 06 September 2016. Capability statements shall be submitted by e-mail only as a Microsoft Word or Adobe PDF attachment to the following address: elsa.delatorre.fn@@mail.mil. Please use subject line "N44852LIFETECHVEID"

Contracting Office address:
3230 Lima Place
Washington, DC 20521 - United States

Primary Point of Contact:
Elsa de la Torre
[email protected]

 

Bid Protests Not Available